⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1369210 | 0.78 | ALDH1A1 (0.50) | — | |
| SCHEMBL6991521 | 0.75 | — | — | |
| SCHEMBL2839473 | 0.74 | — | — | |
| SCHEMBL643261 | 0.74 | — | — | |
| SCHEMBL15948328 | 0.74 | — | — | |
| SCHEMBL11591509 | 0.74 | — | — | |
| SCHEMBL84740 | 0.74 | — | — | |
| SCHEMBL14281292 | 0.74 | — | — | |
| SCHEMBL454310 | 0.74 | — | — | |
| SCHEMBL13879142 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103784449-A | Medicinal composition product containing indacaterol and tiotropium bromide | QINGDAO CHENGYANG PEOPLES HOSPITAL | 2014-05-14 | — | — | CN | claimed |
| CN-103784447-A | Medicinal composition product containing roflumilast and tiotropium bromide | QINGDAO CHENGYANG PEOPLES HOSPITAL | 2014-05-14 | — | — | CN | claimed |
| CN-103784449-A | Medicinal composition product containing indacaterol and tiotropium bromide | QINGDAO CHENGYANG PEOPLES HOSPITAL | 2014-05-14 | — | — | CN | disclosed |
| CN-102256952-B | Arylcyclopropylacetamide derivatives useful as glucokinase activators | LILLY CO ELI | 2013-12-11 | — | — | CN | disclosed |
| US-20130059896-A1 | 5-(1H-PYRAZOL-5-YL)THIAZOLE-BASED COMPOUNDS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE EYE | LEXICON PHARMACEUTICALS, INC. | 2013-03-07 | — | — | US | disclosed |
| EP-2183232-B1 | PI3 KINASE MODULATORS AND METHODS OF USE | AMGEN INC (US) | 2013-03-06 | — | — | EP | disclosed |
| CN-102711758-A | 5-(1H-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye | LEXICON PHARMACEUTICALS INC | 2012-10-03 | — | — | CN | disclosed |
| CN-102516240-A | Heteroaryl-ureas and their use as glucokinase activators | NOVO NORDISK AS | 2012-06-27 | — | — | CN | disclosed |
| CN-1910166-B | Heteroaryl ureas and their use as glucokinase activators | NOVO NORDISK AS | 2012-01-04 | — | — | CN | disclosed |
| WO-2011091204-A1 | 5-(1H-PYRAZOL-5-YL)THIAZOLE-BASED COMPOUNDS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE EYE | LEXICON PHARMACEUTICALS, INC. (US) | 2011-07-28 | — | — | WO | disclosed |
| US-7928140-B2 | Benzothiazole PI3 kinase modulators for cancer treatment | AMGEN INC. (US) | 2011-04-19 | — | — | US | disclosed |
| EP-2183232-A2 | PI3 KINASE MODULATORS AND METHODS OF USE | Amgen, Inc (US) | 2010-05-12 | — | — | EP | disclosed |
| US-20090054405-A1 | PI3 kinase modulators and methods of use | AMGEN INC. (US) | 2009-02-26 | — | — | US | disclosed |
| WO-2009017822-A2 | PI3 KINASE MODULATORS AND METHODS OF USE | AMGEN INC. (US) | 2009-02-05 | — | — | WO | disclosed |